Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Perspectives of the International Society of Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi).

Ciccocioppo R, Baumgart DC, Dos Santos CC, Galipeau J, Klersy C, Orlando G.

Cytotherapy. 2019 Jun 11. pii: S1465-3249(19)30768-6. doi: 10.1016/j.jcyt.2019.05.003. [Epub ahead of print]

PMID:
31201092
2.

Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.

Phinney DG, Galipeau J; MSC COMMITTEE OF THE INTERNATIONAL SOCIETY OF CELL AND GENE THERAPY.

Cytotherapy. 2019 Jun 7. pii: S1465-3249(19)30405-0. doi: 10.1016/j.jcyt.2019.04.003. [Epub ahead of print]

PMID:
31182333
3.

Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach.

Chinnadurai R, Rajakumar A, Schneider AJ, Bushman WA, Hematti P, Galipeau J.

Stem Cells. 2019 May 20. doi: 10.1002/stem.3035. [Epub ahead of print]

PMID:
31108008
4.

Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells.

Chinnadurai R, Sands J, Rajan D, Liu X, Arafat D, Das R, Anania FA, Gibson G, Kisseleva T, Galipeau J.

Stem Cells. 2019 Apr 29. doi: 10.1002/stem.3028. [Epub ahead of print]

PMID:
31033095
5.

Image-Guided Transarterial Directed Delivery of Human Mesenchymal Stem Cells for Targeted Gastrointestinal Therapies in a Swine Model.

Prasanphanich AF, Johnson CT, Krasnopeyev A, Cantara S, Roach C, Gumber S, Chinnadurai R, Galipeau J, Brewster L, Prologo JD.

J Vasc Interv Radiol. 2019 Mar 6. pii: S1051-0443(18)31581-1. doi: 10.1016/j.jvir.2018.09.034. [Epub ahead of print]

PMID:
30852052
6.

Challenges for mesenchymal stromal cell therapies.

Martin I, Galipeau J, Kessler C, Le Blanc K, Dazzi F.

Sci Transl Med. 2019 Feb 20;11(480). pii: eaat2189. doi: 10.1126/scitranslmed.aat2189. Review.

PMID:
30787168
7.

Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.

Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, Chiang KY, Waller EK, Wu R, Gibson G, Roberson J, Lund FE, Randall TD, Sanz I, Lee FE.

Nat Commun. 2019 Jan 17;10(1):372. doi: 10.1038/s41467-019-08400-0.

8.

Response to Nature commentary "Clear up this stem-cell mess".

Galipeau J, Weiss DJ, Dominici M.

Cytotherapy. 2019 Jan;21(1):1-2. doi: 10.1016/j.jcyt.2018.11.007. Epub 2018 Dec 12. No abstract available.

PMID:
30551850
9.

Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells.

Zhang Z, Wilson NA, Chinnadurai R, Panzer SE, Redfield RR 3rd, Reese SR, Galipeau J, Djamali A.

Transplant Direct. 2018 Aug 27;4(9):e387. doi: 10.1097/TXD.0000000000000827. eCollection 2018 Sep.

10.

Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.

Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, Chiang KY, Waller EK, Wu R, Gibson G, Roberson J, Lund FE, Randall TD, Sanz I, Lee FE.

Nat Commun. 2018 Sep 12;9(1):3698. doi: 10.1038/s41467-018-05853-7. Erratum in: Nat Commun. 2019 Jan 17;10(1):372.

11.

Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.

Chadid T, Morris A, Surowiec A, Robinson S, Sasaki M, Galipeau J, Pollack BP, Brewster LP.

J Vasc Surg. 2018 Dec;68(6S):137S-151S.e2. doi: 10.1016/j.jvs.2018.05.223. Epub 2018 Aug 10.

PMID:
30104096
12.

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Galipeau J, Sensébé L.

Cell Stem Cell. 2018 Jun 1;22(6):824-833. doi: 10.1016/j.stem.2018.05.004. Review.

13.

Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells.

Nguyen DC, Lewis HC, Joyner C, Warren V, Xiao H, Kissick HT, Wu R, Galipeau J, Lee FE.

J Extracell Vesicles. 2018 Apr 26;7(1):1463778. doi: 10.1080/20013078.2018.1463778. eCollection 2018.

14.

Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.

Naskou MC, Sumner SM, Chocallo A, Kemelmakher H, Thoresen M, Copland I, Galipeau J, Peroni JF.

Stem Cell Res Ther. 2018 Mar 22;9(1):75. doi: 10.1186/s13287-018-0823-3.

15.

Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Chinnadurai R, Rajan D, Qayed M, Arafat D, Garcia M, Liu Y, Kugathasan S, Anderson LJ, Gibson G, Galipeau J.

Cell Rep. 2018 Feb 27;22(9):2504-2517. doi: 10.1016/j.celrep.2018.02.013.

16.

Adoptive transfer of IL-10+ regulatory B cells decreases myeloid-derived macrophages in the central nervous system in a transgenic amyotrophic lateral sclerosis model.

Pennati A, Asress S, Glass JD, Galipeau J.

Cell Mol Immunol. 2018 Jul;15(7):727-730. doi: 10.1038/cmi.2017.152. Epub 2018 Jan 8. No abstract available.

PMID:
29307886
17.

Innate immune responses of equine monocytes cultured in equine platelet lysate.

Naskou MC, Norton NA, Copland IB, Galipeau J, Peroni JF.

Vet Immunol Immunopathol. 2018 Jan;195:65-71. doi: 10.1016/j.vetimm.2017.11.005. Epub 2017 Nov 16.

PMID:
29249319
18.

The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells.

Lewis HC, Chinnadurai R, Bosinger SE, Galipeau J.

Oncotarget. 2017 Aug 10;8(54):91914-91927. doi: 10.18632/oncotarget.20166. eCollection 2017 Nov 3.

19.

An international survey and modified Delphi process revealed editors' perceptions, training needs, and ratings of competency-related statements for the development of core competencies for scientific editors of biomedical journals.

Galipeau J, Cobey KD, Barbour V, Baskin P, Bell-Syer S, Deeks J, Garner P, Shamseer L, Sharon S, Tugwell P, Winker M, Moher D.

F1000Res. 2017 Sep 4;6:1634. doi: 10.12688/f1000research.12400.1. eCollection 2017.

20.

Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells.

Rajan D, Chinnadurai R, O'Keefe EL, Boyoglu-Barnum S, Todd SO, Hartert TV, Galipeau J, Anderson LJ.

Virology. 2017 Dec;512:144-150. doi: 10.1016/j.virol.2017.09.007. Epub 2017 Sep 28.

21.

Core competencies for scientific editors of biomedical journals: consensus statement.

Moher D, Galipeau J, Alam S, Barbour V, Bartolomeos K, Baskin P, Bell-Syer S, Cobey KD, Chan L, Clark J, Deeks J, Flanagin A, Garner P, Glenny AM, Groves T, Gurusamy K, Habibzadeh F, Jewell-Thomas S, Kelsall D, Lapeña JF Jr, MacLehose H, Marusic A, McKenzie JE, Shah J, Shamseer L, Straus S, Tugwell P, Wager E, Winker M, Zhaori G.

BMC Med. 2017 Sep 11;15(1):167. doi: 10.1186/s12916-017-0927-0.

22.

Stop this waste of people, animals and money.

Moher D, Shamseer L, Cobey KD, Lalu MM, Galipeau J, Avey MT, Ahmadzai N, Alabousi M, Barbeau P, Beck A, Daniel R, Frank R, Ghannad M, Hamel C, Hersi M, Hutton B, Isupov I, McGrath TA, McInnes MDF, Page MJ, Pratt M, Pussegoda K, Shea B, Srivastava A, Stevens A, Thavorn K, van Katwyk S, Ward R, Wolfe D, Yazdi F, Yu AM, Ziai H.

Nature. 2017 Sep 6;549(7670):23-25. doi: 10.1038/549023a. No abstract available.

PMID:
28880300
23.

Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming.

Chinnadurai R, Rajan D, Ng S, McCullough K, Arafat D, Waller EK, Anderson LJ, Gibson G, Galipeau J.

Blood Adv. 2017 Apr 25;1(11):628-643. doi: 10.1182/bloodadvances.2017006205.

24.

Assessing the utility of an institutional publications officer: a pilot assessment.

Cobey KD, Galipeau J, Shamseer L, Moher D.

PeerJ. 2017 May 31;5:e3294. doi: 10.7717/peerj.3294. eCollection 2017.

25.

Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience.

Conklin LS, Hanley PJ, Galipeau J, Barrett J, Bollard CM.

Cytotherapy. 2017 Jun;19(6):655-667. doi: 10.1016/j.jcyt.2017.03.006. Epub 2017 Apr 19. Review.

PMID:
28433516
26.

Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison.

Shamseer L, Moher D, Maduekwe O, Turner L, Barbour V, Burch R, Clark J, Galipeau J, Roberts J, Shea BJ.

BMC Med. 2017 Mar 16;15(1):28. doi: 10.1186/s12916-017-0785-9.

27.

GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Deng J, Li Y, Pennati A, Yuan S, Wu JH, Waller EK, Galipeau J.

Mol Ther. 2017 Feb 1;25(2):416-426. doi: 10.1016/j.ymthe.2016.11.013.

28.

Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.

Stenger EO, Chinnadurai R, Yuan S, Garcia M, Arafat D, Gibson G, Krishnamurti L, Galipeau J.

Biol Blood Marrow Transplant. 2017 May;23(5):736-745. doi: 10.1016/j.bbmt.2017.01.081. Epub 2017 Jan 26.

29.

Reporting quality and risk of bias in randomised trials in health professions education.

Horsley T, Galipeau J, Petkovic J, Zeiter J, Hamstra SJ, Cook DA.

Med Educ. 2017 Jan;51(1):61-71. doi: 10.1111/medu.13130.

PMID:
27981660
30.

Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation.

Pennati A, Ng S, Wu Y, Murphy JR, Deng J, Rangaraju S, Asress S, Blanchfield JL, Evavold B, Galipeau J.

J Neurosci. 2016 Dec 14;36(50):12598-12610. Epub 2016 Nov 7.

31.

Reply: "Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing Is Context Dependent".

Galipeau J.

Stem Cells. 2017 May;35(5):1440-1441. doi: 10.1002/stem.2526. Epub 2016 Nov 14.

32.

Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET).

Phillips AC, Lewis LK, McEvoy MP, Galipeau J, Glasziou P, Moher D, Tilson JK, Williams MT.

BMC Med Educ. 2016 Sep 6;16(1):237. doi: 10.1186/s12909-016-0759-1.

33.

Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.

Ng S, Deng J, Chinnadurai R, Yuan S, Pennati A, Galipeau J.

Cancer Res. 2016 Oct 1;76(19):5683-5695. Epub 2016 Aug 3.

34.

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.

Dhere T, Copland I, Garcia M, Chiang KY, Chinnadurai R, Prasad M, Galipeau J, Kugathasan S.

Aliment Pharmacol Ther. 2016 Sep;44(5):471-81. doi: 10.1111/apt.13717. Epub 2016 Jul 7.

35.

Report on a pilot project to introduce a publications officer.

Cobey KD, Galipeau J, Shamseer L, Moher D.

CMAJ. 2016 Sep 6;188(12):E279-E280. doi: 10.1503/cmaj.151340. Epub 2016 Jun 20. No abstract available.

36.

Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.

Chinnadurai R, Copland IB, Garcia MA, Petersen CT, Lewis CN, Waller EK, Kirk AD, Galipeau J.

Stem Cells. 2016 Sep;34(9):2429-42. doi: 10.1002/stem.2415. Epub 2016 Jul 4.

37.

GIFT4 fusokine converts leukemic B cells into immune helper cells.

Deng J, Pennati A, Cohen JB, Wu Y, Ng S, Wu JH, Flowers CR, Galipeau J.

J Transl Med. 2016 Apr 27;14(1):106. doi: 10.1186/s12967-016-0865-1.

38.

BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.

Deng J, Park D, Wang M, Nooka A, Deng Q, Matulis S, Kaufman J, Lonial S, Boise LH, Galipeau J, Deng X.

Oncotarget. 2016 May 10;7(19):27753-63. doi: 10.18632/oncotarget.8513.

39.

A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.

Robinson ST, Douglas AM, Chadid T, Kuo K, Rajabalan A, Li H, Copland IB, Barker TH, Galipeau J, Brewster LP.

Acta Biomater. 2016 May;36:86-98. doi: 10.1016/j.actbio.2016.03.002. Epub 2016 Mar 4.

40.

A scoping review of competencies for scientific editors of biomedical journals.

Galipeau J, Barbour V, Baskin P, Bell-Syer S, Cobey K, Cumpston M, Deeks J, Garner P, MacLehose H, Shamseer L, Straus S, Tugwell P, Wager E, Winker M, Moher D.

BMC Med. 2016 Feb 2;14:16. doi: 10.1186/s12916-016-0561-2. Review.

41.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L.

Cytotherapy. 2016 Feb;18(2):151-9. doi: 10.1016/j.jcyt.2015.11.008. Epub 2015 Dec 23.

42.

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.

Stenger EO, Krishnamurti L, Galipeau J.

BMC Immunol. 2015 Dec 16;16:74. doi: 10.1186/s12865-015-0135-7. Review.

43.

Effectiveness and safety of short-stay units in the emergency department: a systematic review.

Galipeau J, Pussegoda K, Stevens A, Brehaut JC, Curran J, Forster AJ, Tierney M, Kwok ES, Worthington JR, Campbell SG, Moher D.

Acad Emerg Med. 2015 Aug;22(8):893-907. doi: 10.1111/acem.12730. Epub 2015 Jul 22. Review.

44.

Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.

Granton J, Langleben D, Kutryk MB, Camack N, Galipeau J, Courtman DW, Stewart DJ.

Circ Res. 2015 Sep 11;117(7):645-54. doi: 10.1161/CIRCRESAHA.114.305951. Epub 2015 Jul 20.

PMID:
26195220
45.

Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.

Feng H, Zhang H, Deng J, Wang L, He Y, Wang S, Seyedtabaei R, Wang Q, Liu L, Galipeau J, Compans RW, Wang BZ.

Sci Rep. 2015 Jul 7;5:11856. doi: 10.1038/srep11856.

46.

Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.

Habib J, Deng J, Lava N, Tyor W, Galipeau J.

J Mult Scler (Foster City). 2015 May;2(2). pii: 1000139.

47.

A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency.

Hsieh J, Ng S, Bosinger S, Wu JH, Tharp GK, Garcia A, Hossain MS, Yuan S, Waller EK, Galipeau J.

Clin Transl Immunology. 2015 May 8;4(5):e37. doi: 10.1038/cti.2015.8. eCollection 2015 May.

48.

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.

Chinnadurai R, Ng S, Velu V, Galipeau J.

World J Gastroenterol. 2015 Apr 28;21(16):4779-87. doi: 10.3748/wjg.v21.i16.4779. Review.

49.

B cells for cancer immunotherapy.

Deng J, Galipeau J.

Oncoimmunology. 2014 Dec 15;3(10):e955702. eCollection 2014 Nov.

50.

Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.

Chinnadurai R, Copland IB, Ng S, Garcia M, Prasad M, Arafat D, Gibson G, Kugathasan S, Galipeau J.

Mol Ther. 2015 Jul;23(7):1248-1261. doi: 10.1038/mt.2015.67. Epub 2015 Apr 22.

Supplemental Content

Loading ...
Support Center